This is the authors' abstract. We don't add key points for this paper.
Subarachnoid hemorrhage (SAH) is frequently complicated by acute lung injury (ALI), forming a pathological brain–lung interaction known as the brain–lung axis. Growing evidence suggests that neuroinflammation, autonomic dysregulation, immune alterations, and neuroendocrine signaling collectively contribute to this bidirectional injury process. Mesenchymal stem cell–derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutic agents, as they carry diverse bioactive cargo, including RNAs, proteins, lipids, and mitochondrial components, which can modulate inflammatory responses and promote tissue repair. In this review, we summarize current evidence regarding the role of MSC-EVs in both SAH and ALI, and we discuss how their molecular cargo may influence brain–lung interactions. We pay particular attention to RNA-mediated signaling pathways, mitochondrial transfer, and EVs-associated proteins that regulate neuroinflammation, apoptosis, and barrier integrity in both the brain and lung. We also highlight mechanisms that may contribute to SAH-associated lung injury, including catecholamine surge, systemic inflammatory responses, and immune dysregulation that occur following early brain injury. By integrating findings from studies of SAH, ALI, and extracellular vesicle biology, this review outlines a conceptual framework for understanding how MSC-EVs may modulate the brain–lung axis and discusses their potential as a dual-organ therapeutic strategy for treating SAH-associated ALI. After SAH, inflammatory and neuroendocrine signals drive brain–lung crosstalk, leading to BBB disruption and epithelial damage in the brain and propagating injury in the lung, manifesting as pneumonia and pulmonary edema. MSC-derived extracellular vesicles (MSC-EVs) transport bioactive cargo (including miRNAs and proteins/lipids) to target cells, modulating signaling pathways to reduce neuroinflammation and apoptosis and promote BBB repair, while also suppressing pulmonary inflammation and supporting epithelial recovery via inhibitory effects on key miRNA-linked pathways
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: